Educational guides for peptide research workflows.
Peptide Guides
The gut is the one area where oral delivery is an advantage rather than an obstacle — because the target is the tissue the compound passes through.
Peptide Library Editorial · Sep 6, 2026
Read article →
Peptide Guides
Three groups of compounds get recommended for sleep, on three different rationales. None has the human evidence the recommendations imply.
Peptide Library Editorial · Sep 5, 2026
Read article →
Peptide Guides
A peptide taken by mouth meets the machinery your body uses to digest protein. That single fact explains why almost everything in this category is injected.
Peptide Library Editorial · Sep 4, 2026
Read article →
Peptide Guides
Peptides appear in a great many hair products and in very few trials. The research that exists is mostly topical, mostly small, and mostly about one compound.
Peptide Library Editorial · Sep 3, 2026
Read article →
Peptide Guides
Skin is the one area where peptide evidence is genuinely strongest — and almost all of it is topical, which is exactly the opposite of how these compounds get sold in vials.
Peptide Library Editorial · Sep 1, 2026
Read article →
Peptide Guides
The Wolverine stack is BPC-157 and TB-500 together, named after a character with a healing factor. What each component has actually been studied for, why the composition varies, and what the name obscures.
Peptide Library Editorial · Aug 30, 2026
Read article →
Peptide Guides
Bacteriostatic water is sterile water with 0.9% benzyl alcohol, and that preservative is what makes a peptide vial re-enterable for 28 days. Here is how much to add, how to work out syringe units, and the storage rules that decide when a vial is done.
Peptide Library Editorial · Aug 29, 2026
Read article →
Peptide Guides
Every ingredient in a skinny shot is real and identifiable. The evidence that the combination causes weight loss is the missing part.
Peptide Library Editorial · Aug 23, 2026
Read article →
Peptide Guides
Oral BPC-157 has a better argument behind it than most oral peptides. That argument still has a large gap in it.
Peptide Library Editorial · Aug 20, 2026
Read article →
Peptide Guides
Where to inject and how to inject are two different questions. This is the procedure end to end: preparation, drawing accurately, clearing air, and disposing of sharps properly.
Peptide Library Editorial · Aug 18, 2026
Read article →
Peptide Guides
Copper peptides have a real cosmetic evidence base — and it is topical, which is where most of the confusion starts.
Peptide Library Editorial · Aug 16, 2026
Read article →
Peptide Guides
A weekly subcutaneous injection with three approved sites. Most problems come from rotation, not technique.
Peptide Library Editorial · Aug 14, 2026
Read article →
Peptide Guides
Methylene blue is an approved drug with defined clinical doses — and a drug interaction serious enough to have its own case literature.
Peptide Library Editorial · Aug 10, 2026
Read article →
Peptide Guides
The comparison between oral B12 and injections has been run properly, more than once. The result is not what most clinics imply.
Peptide Library Editorial · Aug 7, 2026
Read article →
Peptide Guides
The decline in NAD+ with age is real. Whether an IV drip reverses anything is a separate question, and the trials are more modest than the clinics.
Peptide Library Editorial · Aug 2, 2026
Read article →
Peptide Guides
Dry powder and mixed solution are two different problems. The powder is stable and tolerates freezing; the solution is fragile, must never be frozen, and is on a clock from the moment you add water.
Peptide Library Editorial · Jul 28, 2026
Read article →
Peptide Guides
Sermorelin has an 11-minute half-life and 29 residues. Both of those numbers argue against a tablet.
Peptide Library Editorial · Jul 25, 2026
Read article →
Peptide Guides
Three approved sites, one weekly dose, and a rotation habit that prevents the problem most people eventually hit.
Peptide Library Editorial · Jul 16, 2026
Read article →
Peptide Guides
These two are combined because they act on different receptors, not the same one harder. The detail that changes everything is whether the CJC-1295 has DAC — and raising growth hormone is not the same as the outcomes it is stacked for.
Peptide Library Editorial · Jul 14, 2026
Read article →
Peptide Guides
These are marketed as topical Botox. The mechanism is real in a dish; getting them to the right place is the whole problem.
Peptide Library Editorial · Jul 13, 2026
Read article →
Peptide Guides
Matrixyl and Matrixyl 3000 are not the same ingredient, which is the first thing worth knowing about them.
Peptide Library Editorial · Jul 11, 2026
Read article →
Peptide Guides
Cosmetic peptides are among the better-evidenced actives in skincare. The labels are also nearly unreadable without a key.
Peptide Library Editorial · Jul 9, 2026
Read article →
Peptide Guides
PT-141 is one of the few peptides here with an approved product and a labelled dose behind it. It is also widely sold as a research chemical, and those two things are not the same proposition.
Peptide Library Editorial · Jul 7, 2026
Read article →
Peptide Guides
Subcutaneous means into the fat layer beneath the skin, not the muscle below it. The four standard sites absorb at different rates, and repeatedly using one spot changes the tissue in ways that alter how much actually gets absorbed.
Peptide Library Editorial · Jun 16, 2026
Read article →
Peptide Guides
These two are constantly paired and often sold pre-blended. A blended vial is where reconstitution arithmetic quietly goes wrong, and the two literatures behind the pair are less alike than the pairing suggests.
Peptide Library Editorial · Jun 2, 2026
Read article →
Peptide Guides
Retatrutide is a triple agonist still in trials — it has no approved dose. Here is the escalation schedule the phase 2 study used, what it produced at 48 weeks, and how the reconstitution arithmetic works.
Peptide Library Editorial · May 5, 2026
Read article →
Peptide Guides
KLOW is GHK-Cu, BPC-157, TB-500 and KPV in one vial, typically 80 mg. What KPV adds over the GLOW blend, what the research on each component actually shows, and how the four-way vial math works.
Peptide Library Editorial · Mar 31, 2026
Read article →
Peptide Guides
TB-500 and thymosin beta-4 are used interchangeably in marketing and are not the same thing. That conflation is where most TB-500 dosing figures come from.
Peptide Library Editorial · Mar 27, 2026
Read article →
Peptide Guides
Almost every BPC-157 dosing chart online traces back to rodent studies that were never designed to produce a human dose. Here is what the literature reports, why the conversion is not straightforward, and how the vial math works.
Peptide Library Editorial · Mar 24, 2026
Read article →
Peptide Guides
Three distinct approaches get grouped under this heading, and they work at different points in the same axis. What they share is how little human evidence supports the use.
Peptide Library Editorial · Feb 13, 2026
Read article →
Peptide Guides
The phrase covers two very different things: approved medicines with large randomised trials, and research compounds with none. Sorting them is most of the work.
Peptide Library Editorial · Jan 30, 2026
Read article →
Peptide Guides
Tesamorelin is one of the few peptides in this category with an actual approved indication and a labelled dose. Knowing what that indication is matters, because almost everything discussed online sits outside it.
Peptide Library Editorial · Jan 27, 2026
Read article →
Peptide Guides
Sermorelin is unusual among research peptides: it was once an approved medicine, withdrawn for commercial rather than safety reasons. That history is why a labelled dose exists at all.
Peptide Library Editorial · Jan 13, 2026
Read article →
Peptide Guides
GLOW is GHK-Cu, BPC-157 and TB-500 in one vial, typically 70 mg. What each component is, what the research on each actually shows, why the ratio is lopsided, and how the reconstitution math works.
Peptide Library Editorial · Jan 2, 2026
Read article →